232
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Multimodal approach to explore the pathogenicity of BARD1, ARG 658 CYS, and ILE 738 VAL mutants

, , , , , , , & show all
Pages 1533-1544 | Received 28 May 2015, Accepted 07 Aug 2015, Published online: 23 Sep 2015

References

  • Ahmed, M., & Rahman, N. (2006). ATM and breast cancer susceptibility. Oncogene, 25, 5906–5911.
  • Alshatwi, A. A., Hasan, T. N., Syed, N. A., Shafi, G., & Grace, B. L. (2012). Identification of functional SNPs in BARD1 gene and in silico analysis of damaging SNPs: Based on data procured from dbSNP database. PLoS One, 7, e43939.10.1371/journal.pone.0043939
  • Amadei, A., Linssen, A. B., & Berendsen, H. J. (1993). Essential dynamics of proteins. Proteins: Structure, Function, and Genetics, 17, 412–425.10.1002/(ISSN)1097-0134
  • Antoniou, A. C., Beesley, J., McGuffog, L., Sinilnikova, O. M., Healey, S., Neuhausen, S. L., … Easton, D. F. (2010). Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction. Cancer Research, 70, 9742–9754.10.1158/0008-5472.CAN-10-1907
  • Birrane, G., Varma, A. K., Soni, A., & Ladias, J. A. (2007). Crystal structure of the BARD1 BRCT domains. Biochemistry, 46, 7706–7712.10.1021/bi700323t
  • Bork, P., Hofmann, K., Bucher, P., Neuwald, A. F., Altschul, S. F., & Koonin, E. V. (1997). A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB Jounal, 11, 68–76.
  • Brzovic, P. S., Meza, J. E., King, M. C., & Klevit, R. E. (2001). BRCA1 RING domain cancer-predisposing mutations: Structural consequences and effects on protein–protein interactions. Journal of Biological Chemistry, 276, 41399–41406.10.1074/jbc.M106551200
  • Brzovic, P. S., Rajagopal, P., Hoyt, D. W., King, M. C., & Klevit, R. E. (2001). Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nature Structural Biology, 8, 833–837.10.1038/nsb1001-833
  • Callebaut, I., & Mornon, J. P. (1997). From BRCA1 to RAP1: A widespread BRCT module closely associated with DNA repair. FEBS Letters, 400, 25–30.10.1016/S0014-5793(96)01312-9
  • Collins, N., McManus, R., Wooster, R., Mangion, J., Seal, S., Lakhani, S. R., … Easton, D. F. (1995). Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene, 10, 1673–1675.
  • De Brakeleer, S., De Grève, J., Loris, R., Janin, N., Lissens, W., Sermijn, E., & Teugels, E. (2010). Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families. Human Mutation, 31, E1175–E1185.10.1002/humu.v31:3
  • Ghimenti, C., Sensi, E., Presciuttini, S., Brunetti, I. M., Conte, P., Bevilacqua, G., & Caligo, M. A. (2002). Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations. Genes, Chromosomes & Cancer, 33, 235–242.
  • Harpaz, Y., Gerstein, M., & Chothia, C. (1994). Volume changes on protein folding. Structure 2: 641–649.10.1016/S0969-2126(00)00065-4
  • Heikkinen, K., Rapakko, K., Karppinen, S. M., Erkko, H., Knuutila, S., Lundan, T., … Winqvist, R. (2006). RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis, 27, 1593–1599.
  • Hess, B., Kutzner, C., van der Spoel, D., & Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4, 435–447.10.1021/ct700301q
  • Jin, Y., Xu, X. L., Yang, M. C., Wei, F., Ayi, T. C., Bowcock, A. M., & Baer, R. (1997). Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proceedings of the National Academy of Sciences, 94, 12075–12080.10.1073/pnas.94.22.12075
  • Kabsch, W., & Sander, C. (1983). Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers, 22, 2577–2637.10.1002/(ISSN)1097-0282
  • Kaminski, G. A., Friesner, R. A., Tirado-Rives, J., & Jorgensen, W. L. (2001). Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. The Journal of Physical Chemistry B, 105, 6474–6487.10.1021/jp003919d
  • Kaplan, W., & Littlejohn, T. G. (2001). Swiss-PDB Viewer (Deep View). Briefings in Bioinformatics, 2, 195–197.10.1093/bib/2.2.195
  • Karppinen, S. M., Barkardottir, R. B., Backenhorn, K., Sydenham, T., Syrjakoski, K., Schleutker, J., … Winqvist, R. (2006). Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies. Journal of Medical Genetics, 43, 856–862.10.1136/jmg.2006.041731
  • Karppinen, S.-M., Heikkinen, K., Rapakko, K., & Winqvist, R. (2004). Mutation screening of the BARD1 gene: Evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer. Journal of Medical Genetics, 41, 856–862.10.1136/jmg.2004.020669
  • Kolchanov, N. A., Soloviov, V. V., & Zharkikh, A. A. (1983). The effects of mutations, deletions and insertions of single amino acids on the three-dimensional structure of globins. FEBS Letters, 161, 65–70.10.1016/0014-5793(83)80731-5
  • Li, M., & Yu, X. (2013). Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. Cancer Cell, 23, 693–704.10.1016/j.ccr.2013.03.025
  • Meijers-Heijboer, H., van den Ouweland, A., Klijn, J., Wasielewski, M., de Snoo, A., Oldenburg, R., … Stratton, M. R. (2002). Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature Genetics, 31, 55–59.10.1038/ng879
  • Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., … Skolnick, M. H. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66–71.10.1126/science.7545954
  • Mohammad, D. H., & Yaffe, M. B. (2009). 14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response. DNA Repair, 8, 1009–1017.10.1016/j.dnarep.2009.04.004
  • Pace, C. N. (1986). Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods in Enzymology, 131, 266–280.10.1016/0076-6879(86)31045-0
  • Pace, C. N., & Shaw, K. L. (2000). Linear extrapolation method of analyzing solvent denaturation curves. Proteins: Structure, Function, and Genetics, 41, 1–7.10.1002/(ISSN)1097-0134
  • Rapakko, K., Heikkinen, K., Karppinen, S. M., Erkko, H., & Winqvist, R. (2007). Germline alterations in the 53BP1 gene in breast and ovarian cancer families. Cancer Letters, 245, 337–340.10.1016/j.canlet.2006.01.021
  • Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., … Rahman, N. (2006). ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nature Genetics, 38, 873–875.10.1038/ng1837
  • Ryckaert, J.-P., Ciccotti, G., & Berendsen, H. J. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. Journal of Computational Physics, 23, 327–341.10.1016/0021-9991(77)90098-5
  • Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997). Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell, 90, 425–435.10.1016/S0092-8674(00)80503-6
  • Thai, T. H., Du, F., Tsan, J. T., Jin, Y., Phung, A., Spillman, M. A., … Bowcock, A. M. (1998). Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Human Molecular Genetics, 7, 195–202.10.1093/hmg/7.2.195
  • Thanassoulas, A., Nomikos, M., Theodoridou, M., Yannoukakos, D., Mastellos, D., & Nounesis, G. (2010). Thermodynamic study of the BRCT domain of BARD1 and its interaction with the -pSER-X-X-Phe- motif-containing BRIP1 peptide. Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics, 1804, 1908–1916.10.1016/j.bbapap.2010.04.012
  • Vikrant, Kumar, R., Yadav, L. R., Nakhwa, P., Waghmare, S. K., Goyal, P., & Varma, K. (2013). Structural and functional implication of RAP80 ΔGlu81 mutation. PLoS One, 8, e72707.10.1371/journal.pone.0072707
  • Vikrant, Nakhwa, P., Badgujar, D. C., Kumar, R., Rathore, K. K. S., & Varma A. K. (2014). Structural and functional characterization of the MERIT40 to understand its role in DNA repair. Journal of Biomolecular Structure and Dynamics, 32, 2017–2032.10.1080/07391102.2013.843473
  • Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., ... Averill, D. (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science, 265, 2088–2090.10.1126/science.8091231
  • Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., … Baer, R. (1996). Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nature Genetics, 14, 430–440.10.1038/ng1296-430
  • Wu-Baer, F., Lagrazon, K., Yuan, W., & Baer, R. (2003). The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional Linkage involving lysine residue K6 of ubiquitin. Journal of Biological Chemistry, 278, 34743–34746.10.1074/jbc.C300249200
  • Yoshikawa, K., Ogawa, T., Baer, R., Hemmi, H., Honda, K., Yamauchi, A., … Takahashi, R. (2000). Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas. International Journal of Cancer, 88, 28–36.10.1002/(ISSN)1097-0215
  • Zhukov, I., Jaroszewski, L., & Bierzynski, A. (2000). Conservative mutation Met8 --> Leu affects the folding process and structural stability of squash trypsin inhibitor CMTI-I. Protein Science, 9, 273–279.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.